José Ramón Paño‐Pardo
Instituto de Salud Carlos III(ES)Centro de Investigación Biomédica en Red(ES)Hospital Clínico Universitario Lozano Blesa(ES)Instituto de Investigación Sanitaria Aragón(ES)European Society of Clinical Microbiology and Infectious Diseases(CH)
Publications by Year
Research Areas
Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, COVID-19 Clinical Research Studies, Antibiotics Pharmacokinetics and Efficacy
Most-Cited Works
- → Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study(2017)511 cited
- → Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH(2011)195 cited
- → ESCMID COVID-19 living guidelines: drug treatment and clinical management(2021)175 cited
- → Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients(2017)147 cited
- → A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae(2016)116 cited
- → A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia